· Strategic Management Theory : An Integrated Approach (6th edition), Hill, Charles & Jones, Gareth, South Western Educational Publishing, 2004
· Kumar, Nirmalya, How emerging giants are rewriting the rules of M&A, Harvard Business Review, 2009
· Killing, Peter, & Beamish, Paul, The design and management of international joint ventures, In Beemish, Paul W., Morrision, Allen., & Rosenzweig, Philip M. International management: Text and cases (3rd Ed.). Iwrin., 1997
· 하재건, 우리나라의 발전 방향에 관한 연구, 석사학위논문, 단국대학교 경영대학원, 2010
· 일본의 의약품 시장 동향,한국보건산업진흥원, 2008
· 일본 제네릭 의약품 시장 동향, KIET 해외산업정보, 2009
· 윤동섭, 일본 제약산업의 발전과정과 공공정책 및 미래상, 산업동향 2008-1, BT산업동향보고서, 생명공학정책연구센터, 2008
· 이재형, 국내외 주요 바이오제약기업의 R&D 현황 분석, BT 산업동향보고서, 생명공학정책연구센터, 2011
· 고은지, 전환기의 세계 제약산업 경쟁양상이 달라진다, LG주간경제, 2001
· 최영, 국내 바이오의약품의 진화, Credit Rating Weekly, Korea Investors Service, Inc., 2008
· 윤수영, 글로벌 제약산업에 부는 변화의 바람, LG Business Insight 2013 1 16, 2013
· 정효진, 일본 제약 업종: 다나까 상의 약값은 어떻게 되었을까?, 일본탐방분석시리즈3, 한화증권, 2010
· 중국기업의 세계M&A시장 진출 전략 연구 : 중국국유기업 해외 M&A 사례를 중심으로, 김해령, pp.7-11, 경희대학교, 2009
· M&A 전략과 실전 사례, 윤종훈, 매일경제신문사, p.30
· 미국의 의약품 시장 동향, 한국보건산업진흥원, 2008.05.02
· 글로벌 제약 시장의 환경 변화, 2010 KDHI 통계분석리포트 Vol.04, 한국보건산업진흥원, 2010.12
· 2011일본 화학산업 동향<의약품산업>, 정밀화학정책연구센터, 한국화학연구원, 2011
· Gurumurthy Kalyanaram, Ragu Gurumuthy, Market Entry Strategies: Pioneers Versus Late Arrivals, 1998.07.01
· 일본 제약사 및 원료의약품 기업 탐방 : 2013 Outlook 패턴트폴을 넘는 Generics, 동양증권 리서치센터, 2012
· 김나연, 일본 불황에서 제약산업의 미래를 바라보다, KDB 대우증권
· Peter Gwynne, Leadership, Stability, and Social Responsibility, AAAS/Science Business Office Feature, 2008
· 김태희, 제약/바이오, X-book, 동부증권 리서치센터, 2010
· Byoung-Goo Kim·Gyu-Bae Kim, Late Movers’ MarketEntry Strategies in the Chinese Retail Market: The case of a Korean Company, Journal of Distribution Science 10-11, 2012
· Brian DeSchuytner·Kyle Kuvalanka·Barbara Hibner and Joseph Bolen, Takeda’s Oncology Discovery Strategy, Japanese Journal of Clinical Oncology, 2013.03.14
· Personalized Medicine in Oncology, Global Biomarkers Consortium, 2012.05
· 조성우, 글로벌 R&D, M&A 트랜드, 제약 산업의 미래, 바이오의약품 2.0, 약사신문, 2011.03.30
· Christin Melton, Millennium Thrives after Takeda Takeover, Physicians’Financial News, 2009.05
· Robert Weisman, Cultural Synergy at Millennium Pharmaceuticals, The Boston Globe, 2012.11.04
· Kanoko Matsuyama, Takeda Will Change Researchers Compensation to Boost Quality, Bloomberg, 2009.05.11
· Millennium Pharmaceuticals backs performance-based stock option grants, Pensions&Investments, 2006.03.28
· PharmXpert Academy, http://www.pharmxpert.net/web/board/b_ne01upload/%EC%A0%9C%EC%95%BD%20%EB%B0%94%EC%9D%B4%EC%98%A4%20%EC%95%BD%ED%92%88%EC%9D%98%20%EB%AF%B8%EB%9E%98.pdf
· Feature 2: Becoming a Sustainable Organization, http://www.takeda.com/csr/reports/pdf/index/ar2011_07_en.pdf
· 해외 진출의 유형, 기업금융나들목, http://www.smefn.or.kr/gs01/sales/abrgudie01.jsp
· An interview on the takeda acquisition with lisa adler, vp, corporate communications, millennium: the takeda oncology company, Snapshot, 2011.05.13, http://www.raymondstevenson.com/this-weeks-post/a-three-part-interview-with-lisa-adler-vp-corporate-communications-millennium-the/
· Takeda Chemical Industries, Ltd., Porter Prize, http://www.porterprize.org/english/pastwinner/2002/12/03141615.html
· Takeda lifts limits on payments, Chemical & Engineering News, Volume 82, Number 29, 2004.07.19, http://pubs.acs.org/cen/news/8229/print/8229notw7.html
· Compensation and talent committee report on executive compensation, Compensation and Talent Committee, http://yahoo.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHtmlSection1?SectionID=3554843-107334-120891&SessionID=57LqFq0H3PaDcJ7
· Special Feature_2 An Outstanding Oncology Strategy, http://www.takeda.com/csr/reports/pdf/index/ar2009_08_en.pdf
· Takeda Pharmaceutical Company Limited, “Annual Report 2008, Mar. 2008, http://www.takeda.com
· Takeda Pharmaceutical Company Limited, “Annual Report 2009, Mar. 2009, http://www.takeda.com
· Takeda Pharmaceutical Company Limited, “Annual Report 2010, Mar. 2010, http://www.takeda.com
· Takeda Pharmaceutical Company Limited, “Annual Report 2011, Mar. 2011, http://www.takeda.com
· Takeda Pharmaceutical Company Limited, “Annual Report 2012, Mar. 2012, http://www.takeda.com
· Takeda Pharmaceutical Company Limited, “Annual Report 2013, Mar. 2013, http://www.takeda.com
· Millennium, Pharmaceuticals, Inc., “FDA Grants Priority Review For Velcade(R) (bortezomib) for Injection In Patients with Newly Diagnosed Multiple Myeloma”, Jan. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma”, Feb. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Millennium Expands VELCADE(R) (Bortezomib) For Injection Program In Non-Hodgkin's Lymphoma”, Feb. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients”, May. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Takeda to Acquire Millennium for US$25.00 Per Share in an All Cash Tender Offer Valued at $8.8 Billion”, Apr. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales”, Apr. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Takeda Successfully Completes Tender Offer for Millennium Pharmaceuticals, Inc. and Announces Subsequent Offering Period”, Apr. 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Takeda Completes Acquisition of Millennium”, May 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “Velcade(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients with Newly Diagnosed Multiple Myeloma”, May 2008, http://www.millennium.com
· Millennium, Pharmaceuticals, Inc., “MILLENNIUM ADVANCES ONCOLOGY PIPELINE”, Jul 2008, http://www.millennium.com
· Scrip : world pharmaceutical news, “Takeda to acquire Millennium”, Apr. 2008, http://www.scripnews.com
· Physicians’ Financial News, “Millennium Thrives after Takeda Takeover, 2009 http://www.hcplive.com
· 송재용, “스마트 경영”, 21세기북스, 2011
· 데이비드 하딩, “M&A마스터”, 청담, 2008
· 가네마키 류이치, 마루야마 히로시, 가와이 다카노, “M&A 승패 : 합병 후 통합 과정에 달려 있다”, 한국경제신문, 2007
· 장세진. MCC, “M&A의 경영전략”, 박영사, 2004
· 한국 M&A 협회, “실전 M&A 특강, 새로운 제안, 2006
· 윤종훈, “M&A 전략과 실전사례 : 대중적이면서도 이론과 실전을 겸비한 M&A 매뉴얼”, 매일경제신문사, 2005
· 김창일, “M&A 핸드북”, 영화조세통람, 2003
· 이운승, “기술적 동기에 의한 M&A의 성공요인 분석”, 석사학위논문, 서울대학교 대학원, 2012
· 김나연, “일본 불황에서 제약산업의 미래를 바라보다”, KDB 대우증권, 2012
· 정성춘, “일본 M&A 시장의 최근 동향과 과제”, KIEP 대외경제정책연구원, 2005
· 김태희, “제약, 평범한 건 거부한다”, 동부증권, 2009
· 윤수영, “무한경쟁 시대의 제약기업 생존전략”, LG ERI 리포트, 2008
· 엄기현, “해외 M&A를 통한 제약산업 경쟁력 강화 방안”, 한국정책금융공사, 2012
· 고유상, “세계 바이오제약산업의 M&A 동향”, 삼성경제연구소, 2007
· 윤수영, “제약기업 성장을 위한 M&A의 역할”, LG ERI 리포트, 2009
· 김종태, “M&A 전략 및 가치평가”, 중수기업연구원, 2008
· Yasuchika Hasegawa, “Takeda Acquires Millennium Pharmaceuticals Inc., Takeda Pharmaceutical Company Limited, 2008
· Deborah Dunsire, “Building Toward Leadership in Oncology”, Millennium: The Takeda Oncology Company, 2008
· Nancy Simonian, “The Takeda Millennium Acquisition: The Clinical Outsourcing Roadmap to Market Leadership in Oncology”, Millennium: The Takeda Oncology Company, 2010
· Narayanan Suresh, “Takeda’s bold move on Millennium”, BioEdit, 2008
· 고재학(2009), “금융합병 성과평가로서 PMI에 관한연구:우리은행 인사통합관리에 관한 인식차이 중심으로”, 중앙대학교 국가정책연구소
· 김진규(2006), “M&A 목표달성을 위한 PMI 관리전략 및 과정에 대한 연구,” 서울대학교.
· 김종대(2011), “M&A 이후의 성공적 PMI 전략에 대한 연구”, 대한 경영학회
· 박노화(2001) “제약산업의 기업 인수합병에 관한 연구 : 워너램버트와 화이자 사례”, 연세대학교 경영대학원.
· Mittchell Lee Marks and Philip H. Mirvis(2001), “Making mergers and acquisitions work: Strategic and psychological preparation”, Academy of management executive.
· Nahavandi, A. & Malekzadeh, A. R.(1998), Acculturation in mergers and acquisitions, Academy of Management Review
· Yaakov Wever and Shlomo Yedidia Tarba(2012), “Mergers and acquisitions process: the use of corporate culture analysis”, Cross cultural Management
· 신동엽, 권수라(2008), 국제합작투자에서 학습 딜레마와 파트너 기업간 신뢰, 한국전략경영학회
· Killing, Peter., & Beamish, Paul. 1997. “The design and management of international joint ventures.” In Beemish, Paul W., Morrison, Allen.,& Rosenzweig, Phillip M. International management:Text and cases(3rd Ed.) Irwin
· 송재용, 스마트경영, 21세기북스, 2011